Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Radiation Oncology
Residual disease
Questions discussed in this category
Based on data from CREATE-X/JBCRG-04, would you consider adjuvant capecitabine in breast cancer patients treated with neoadjuvant chemotherapy who do not achieve a pCR?
Masuda et al. NEJM 2017 If so, how do you sequence it with adjuvant radiotherapy?
2 Answers available
924
Papers discussed in this category
N. Engl. J. Med.,
Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy.
Related Topics in Radiation Oncology
Lung Cancer
Workload
Breast Cancer
Head and Neck Cancers
Hematologic Malignancies
Gynecologic Cancers
Palliation
Neuro-Oncology
Gastrointestinal Cancers
Genitourinary Cancers